Q2 saw strong growth in specialty short-tail lines, with 14.3% operating ROE and 15% book value growth year-over-year. Despite market softening and CAT losses, disciplined underwriting and capital returns continued, while investments in technology and talent support long-term strategy.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.